Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis

doi:10.1590/1806-9282.20240322

Meta-Analysis

. 2024 Aug 16;70(8):e20240322.

doi: 10.1590/1806-9282.20240322. eCollection 2024.

Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis

Affiliations

¹ Tabriz University of Medical Sciences, Research Center for Evidence-Based Medicine, Iranian EBM Center: A JBI Center of Excellence - Tabriz, Iran.
² Tabriz University of Medical Sciences, Hematology and Oncology Research Center - Tabriz, Iran.
³ Tabriz University of Medical Sciences, Aging Research Institute, Research Center for Integrative Medicine in Aging - Tabriz, Iran.
⁴ Tabriz University of Medical Sciences, School of Medicine, Department of Internal Medicine - Tabriz, Iran.
⁵ Tabriz University of Medical Sciences, Medical Philosophy and History Research Center - Tabriz, Iran.
⁶ Tabriz University of Medical Sciences, Liver and Gastrointestinal Diseases Research Center - Tabriz, Iran.
⁷ Ardabil University of Medical Sciences, School of Medicine, Student Research Committee - Ardabil, Iran.
⁸ Tabriz University of Medical Sciences, Clinical Research Development Unit of Tabriz Valiasr Hospital - Tabriz, Iran.

PMID: 39166680
PMCID: PMC11329259
DOI: 10.1590/1806-9282.20240322

Meta-Analysis

Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis

Mohammad Amin Akbarzadeh et al. Rev Assoc Med Bras (1992). 2024.

. 2024 Aug 16;70(8):e20240322.

doi: 10.1590/1806-9282.20240322. eCollection 2024.

Authors

Affiliations

¹ Tabriz University of Medical Sciences, Research Center for Evidence-Based Medicine, Iranian EBM Center: A JBI Center of Excellence - Tabriz, Iran.
² Tabriz University of Medical Sciences, Hematology and Oncology Research Center - Tabriz, Iran.
³ Tabriz University of Medical Sciences, Aging Research Institute, Research Center for Integrative Medicine in Aging - Tabriz, Iran.
⁴ Tabriz University of Medical Sciences, School of Medicine, Department of Internal Medicine - Tabriz, Iran.
⁵ Tabriz University of Medical Sciences, Medical Philosophy and History Research Center - Tabriz, Iran.
⁶ Tabriz University of Medical Sciences, Liver and Gastrointestinal Diseases Research Center - Tabriz, Iran.
⁷ Ardabil University of Medical Sciences, School of Medicine, Student Research Committee - Ardabil, Iran.
⁸ Tabriz University of Medical Sciences, Clinical Research Development Unit of Tabriz Valiasr Hospital - Tabriz, Iran.

PMID: 39166680
PMCID: PMC11329259
DOI: 10.1590/1806-9282.20240322

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare there is no conflicts of interest.

Figures

**Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analysis flow diagram of the study.**

**Figure 2. Pooled analysis for risk of mortality (a) and hospitalization (b) in chronic lymphocytic leukemia patients with COVID-19 infection.**

See this image and copyright information in PMC

References

1. Akbarzadeh MA, Hosseini MS. Implications for cancer care in Iran during COVID-19 pandemic. Radiother Oncol. 2020;148(148):211–212. doi: 10.1016/j.radonc.2020.04.041. - DOI - PMC - PubMed
1. Griggio V, Perutelli F, Salvetti C, Boccellato E, Boccadoro M, Vitale C, et al. Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia. Front Immunol. 2020;11:594556–594556. doi: 10.3389/fimmu.2020.594556. - DOI - PMC - PubMed
1. Vitale C, Boccellato E, Comba L, Jones R, Perutelli F, Griggio V, et al. Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia. Cancers (Basel) 2021;13(15):3856–3856. doi: 10.3390/cancers13153856. - DOI - PMC - PubMed
1. Williams AM, Baran AM, Meacham PJ, Feldman MM, Valencia HE, Newsom-Stewart C, et al. Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies. Leuk Lymphoma. 2018;59(3):625–632. doi: 10.1080/10428194.2017.1347931. - DOI - PubMed
1. Hosseini M-S, Jahanshahlou F, Akbarzadeh MA, Zarei M, Vaez-Gharamaleki Y. Formulating research questions for evidence-based studies. J Med Surg Public Health. 2024;2:100046–100046. doi: 10.1016/j.glmedi.2023.100046. - DOI

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- PubMed Central
- Scientific Electronic Library Online
Medical
- MedlinePlus Health Information

[1] Akbarzadeh MA, Hosseini MS. Implications for cancer care in Iran during COVID-19 pandemic. Radiother Oncol. 2020;148(148):211–212. doi: 10.1016/j.radonc.2020.04.041. - DOI - PMC - PubMed

[2] Akbarzadeh MA, Hosseini MS. Implications for cancer care in Iran during COVID-19 pandemic. Radiother Oncol. 2020;148(148):211–212. doi: 10.1016/j.radonc.2020.04.041. - DOI - PMC - PubMed

[3] Griggio V, Perutelli F, Salvetti C, Boccellato E, Boccadoro M, Vitale C, et al. Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia. Front Immunol. 2020;11:594556–594556. doi: 10.3389/fimmu.2020.594556. - DOI - PMC - PubMed

[4] Griggio V, Perutelli F, Salvetti C, Boccellato E, Boccadoro M, Vitale C, et al. Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia. Front Immunol. 2020;11:594556–594556. doi: 10.3389/fimmu.2020.594556. - DOI - PMC - PubMed

[5] Vitale C, Boccellato E, Comba L, Jones R, Perutelli F, Griggio V, et al. Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia. Cancers (Basel) 2021;13(15):3856–3856. doi: 10.3390/cancers13153856. - DOI - PMC - PubMed

[6] Vitale C, Boccellato E, Comba L, Jones R, Perutelli F, Griggio V, et al. Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia. Cancers (Basel) 2021;13(15):3856–3856. doi: 10.3390/cancers13153856. - DOI - PMC - PubMed

[7] Williams AM, Baran AM, Meacham PJ, Feldman MM, Valencia HE, Newsom-Stewart C, et al. Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies. Leuk Lymphoma. 2018;59(3):625–632. doi: 10.1080/10428194.2017.1347931. - DOI - PubMed

[8] Williams AM, Baran AM, Meacham PJ, Feldman MM, Valencia HE, Newsom-Stewart C, et al. Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies. Leuk Lymphoma. 2018;59(3):625–632. doi: 10.1080/10428194.2017.1347931. - DOI - PubMed

[9] Hosseini M-S, Jahanshahlou F, Akbarzadeh MA, Zarei M, Vaez-Gharamaleki Y. Formulating research questions for evidence-based studies. J Med Surg Public Health. 2024;2:100046–100046. doi: 10.1016/j.glmedi.2023.100046. - DOI

[10] Hosseini M-S, Jahanshahlou F, Akbarzadeh MA, Zarei M, Vaez-Gharamaleki Y. Formulating research questions for evidence-based studies. J Med Surg Public Health. 2024;2:100046–100046. doi: 10.1016/j.glmedi.2023.100046. - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis

Affiliations

Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical